Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periocular comparison of different-dose intravitreal triamcinolone acetonide for macular edema due to retinal vein occlusion
ChiCTR-TRC-10000997Phase 4Completed
- Sponsor
- Xi'an People's Hospital
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of triamcinolone acetonide in Vein occlusion (RVO) (3 arms), sponsored by Xi'an People's Hospital. Primary endpoints: Intraocular pressure, Fundus fluorescein angiography and 2 more. Started Sep 2008; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
Vein occlusion (RVO)
Beyond the preview
Go deeper on ChiCTR-TRC-10000997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000997.